Serum soluble suppression of tumorigenicity‐2 level associates with severity of pulmonary hypertension associated with uncorrected atrial septal defect

Uncorrected atrial septal defect undergoes right ventricle chronic volume overload which may lead to pulmonary hypertension and Eisenmenger Syndrome. The soluble suppression of tumorigenicity‐2 is a left ventricle strain biomarker; however, its role in right ventricle strain is unclear. This study aimed to investigate the implication of serum soluble suppression of tumorigenicity‐2 in adult uncorrected atrial septal defect. This was a...